Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 25, 2026.

Rapid review of evaluation of interventions to improve participation in cancer screening services

Stephen W Duffy, Jonathan P Myles, Roberta Maroni and 1 more

Journal of Medical Screening · 2016

doi:10.1177/0969141316664757

Abstract

Objective. Screening participation is spread differently across populations, according to factors such as ethnicity or socioeconomic status. We here review the current evidence on effects of interventions to improve cancer screening participation, focussing in particular on effects in underserved populations.

Methods. We selected studies to review based on their characteristics: focussing on population screening programmes, showing a quantitative estimate of the effect of the intervention, and published since 1990. To determine eligibility for our purposes, we first reviewed titles, then abstracts, and finally the full paper. We started with a narrow search and expanded this until the search yielded eligible papers on title review which were less than 1% of the total. We classified the eligible studies by intervention type and by the cancer for which they screened, while looking to identify effects in any inequality dimension.

Results. The 68 papers included in our review reported on 71 intervention studies. Of the interventions, 58 had significant positive effects on increasing participation, with increase rates of the order of 2%–20% (in absolute terms).

Conclusions. Across different countries and health systems, a number of interventions were found more consistently to improve participation in cancer screening, including in underserved populations: pre-screening reminders, general practitioner endorsement, more personalized reminders for non-participants, and more acceptable screening tests in bowel and cervical screening.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 25, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

To achieve their desired public health impact, population cancer screening services require high levels of participation. While it is agreed that decisions to participate in cancer screening should be free from undue pressure, and should be well-informed, it is also frequently observed that there are considerable inequalities in participation in cancer screening.– In the United Kingdom (UK), screening participation rates are lower in areas of deprivation and among certain ethnic groups.– There is a wide range of potential interventions to improve access to cancer screening services and, therefore, increase participation. Given the perceived need to address health inequalities, one tactic would be to improve uptake of public health measures such as screening programmes in currently underserved populations. We review the evidence on effects of interventions to improve screening participation, with particular reference to effects on inequalities. To inform policy and practice, such a review should identify those measures most and least likely to be effective, including any findings with respect to inequalities, or effects of interventions in deprived or otherwise underserved populations.

Methods

We specified in advance that the studies of relevance to this review had to report on interventions aimed at participation in cancer screening services (not randomized trials of screening). The focus of interest was population screening programmes (as opposed to surveillance of specific genetic or other high-risk groups). To be eligible, a study had to report a quantitative estimate of the effect of the intervention on participation rates. We only included studies published since 1990. Studies which assessed the effect of personal invitation against no invitation were not included, as the NHS Cancer Screening Programmes in the UK would always send personal invitations in any case.

The commissioners of this research required results in a relatively short time and resources were not available for the traditional systematic review. Therefore, rather than the customary search strategy which begins as comprehensively as possible and frequently identifies tens of thousands of populations, we started with a narrow search and expanded successively (by adding ‘OR’ terms) until the number of new publications eligible on title review comprised less than 1% of the total. The major assumption here was that if successive expansions of the search yield diminishing numbers of potentially eligible publications, and if the most recent expansion yields a relatively small addition to the pool, stopping the expansion at this point is unlikely to lead to a major loss of information. The successive searches and their outcomes are shown in Table 1. As this strategy is less comprehensive than the standard systematic review procedure, as a further safeguard, we also specified that the publications yielded by the final search had to include four recent studies which were clearly relevant.– The other restriction was that only peer-reviewed results obtainable in PubMed searches were considered. Searches took place in late September 2015.

Papers passing title review underwent abstract review. Those remaining eligible after abstract review underwent full paper review. In addition to original papers, our searches identified five reviews.– From these, and from the reference lists of the papers eligible after full paper review, we identified further potential papers which, in turn, were subject to abstract and, if eligible, full paper review. Finally, colleagues identified evaluations of eight interventions published in three papers since the searches took place.–

Papers were reviewed for the effect of the intervention by the cancer for which they were screening and by intervention type (reminders in addition to usual invitation; primary care endorsement; additional interventions in non-participants; enhanced invitation materials or varying invitation strategy; direct contact; varying the screening test). Interventions can occur at various stages of the process, from advance notice communications sent prior to first invitation to screening, to the offer of a different screening test at the screening episode some years following non-participation in a previous episode (see Figure 1). We deal with the arbitrary nature of the classification below (see Discussion section). In addition, interventions were studied to identify effects by different socioeconomic or ethnic grouping, if any, and to identify any other inequality dimension in the work.

In the description of results of interventions below, percentage increases in participation refer to absolute increases; for example, a 5% increase would refer to a difference between 20% and 25% (an absolute increase of 5%) rather than 20% and 21% (a 5% relative increase).

Results

After abstract review, 62 papers were deemed eligible. On full paper review, two were excluded, leaving 60. From reference lists and reviews, after full paper review, further five papers were added. As noted above, colleagues identified another three papers published since the searches, bringing the total to 68 papers included, although one reports on four separate trials and is therefore included four times in the tables of results.

Reminders in addition to usual invitation

Results are shown in Table 2. Eleven papers were identified, two in colorectal, six in breast, two in cervical and one in stomach cancer screening.,,– Ten of the 11 reported an increase in participation with reminders (3/3 text reminder studies; 4/5 telephone reminder studies; 2/2 postal reminder studies; 1/1 telephone + postal reminder study). The absolute magnitude of the effects was an increase in participation of the order of between 3 and 10 percentage points. Most studies were in urban areas, including substantial underserved and low socioeconomic status populations. All seven of the studies explicitly reporting results in such underserved populations found an increase in participation with the intervention.,,,–

Primary care endorsement

Results are shown in Table 3. Twelve studies were identified, six in colorectal, four in breast, and two in cervical cancer screening.,,– Ten of the 12 reported positive results. One of the studies which did not find increased participation was in the context of a flexible sigmoidoscopy project in the UK before flexible sigmoidoscopy was included in the national programme, and rather than a letter with general practitioner (GP) endorsement, the intervention was the offer of a consultation with the GP to discuss the screening. Typical increases in participation of the order of 2%–3% were observed, but some studies found increases of 10%–20%. All four studies explicitly reporting the effect in underserved populations found an increase in participation with the intervention.,,, One study of a multilingual intervention aimed at ethnic minorities in Cardiff found an increase in participation in people of south Asian origin, higher in Gujarati and Urdu speakers than in Bengali speakers.

Interventions targeted specifically on non-participants

Results are shown in Table 4. Fifteen studies were identified, three in colorectal, eight in breast, and four in cervical cancer screening.,– Twelve of the fifteen studies found an increase in participation with the intervention; 3/6 telephone reminder studies had positive results, compared to 7/7 postal interventions (including two where the letter was from the subject's own GP), 1/1 study of combined telephone and postal reminders, and 1/1 which found increased participation with sending a second faecal occult blood test (FOBT) kit instead of a reminder letter. Typical effect sizes were of the order of a 10% increase in participation with reminder letters, and rather smaller effects with telephone reminders. Very large effects were noted for reminder letters compared with no further contact, but as the former is standard practice in the UK, there is no policy change implied by this result. Substantially greater participation was observed for second timed appointment for breast screening non-attenders, compared with open invitation to call and make an appointment. One study of an enhanced reminder letter, one of additional reminder letters, and two studies of telephone reminders reported positive results in underserved populations.,,,

Varying invitation materials or strategy

Results are shown in Table 5. Eighteen intervention studies reported in 17 papers were identified, 11 in colorectal, four in breast, one in cervical, one in breast and cervical, one in melanoma screening.,,,–,–,– The 17 papers reported on evaluation of 20 interventions; some studies evaluated more than 1 intervention simultaneously. Thirteen interventions were observed to be associated with increased participation. Enclosing survey questionnaires with the invitation had little effect on participation, and one study found a significantly reduced participation with the intervention, with the reduction greatest in deprived areas., Fixed screening appointment times compared with open invitations increased participation by around 20% (in absolute terms), and one study found a 3% increase when the invitation included the opportunity to switch to an evening or weekend appointment time for breast cancer screening., The latter took place in Manchester and Bristol, both of which included areas of deprivation. Out of five studies (in four publications) of varying the information with the invitation, only one found an increase in participation with the intervention.,,, Two studies of advance notice of the screening invitation found an increase in participation., One study found an increased participation rate with the offer of a health check, and another found no increase with the offer of counselling. Two out of three evaluations of mass media campaigns found an increase in participation.,, Two studies found that direct mailing of FOBT kits led to higher participation than the request to collect a kit at primary care., One found increased participation with the mailing of a pack of equipment with the FOBT kit, including latex gloves and stool catchers to facilitate collection of stool samples.

Direct contact interventions

Results are shown in Table 6. Five studies were identified, one in colorectal, three in breast, and one in cervical cancer screening.,–, Three studies were of home visits, two finding increased participation associated with the intervention.,, One study of direct telephone contact by a health professional found an increase in participation with the intervention. One study of opportunistic promotion of breast screening at clinic attendances for other reasons found an increase in participation, especially in women of low socioeconomic status.

Varying the screening test

Results are shown in Table 7. Ten studies were identified, three in colorectal– and seven in cervical screening.– Faecal immunochemical testing (FIT) yielded 15%–20% higher participation rates than either colonoscopy or guaiac FOBT. The improvements over both colonoscopy and guaiac FOBT did not vary substantially by age, sex, or ethnicity. One study in Germany comparing conventional with capsule colonoscopy found a small increase in participation with the latter. All the cervical screening studies were of the offer of human papillomavirus (HPV) self-sampling, usually to women with a history of non-participation,– and all found increased participation with the offer of self-sampling, typically of the order of 10%. The one study reporting effects by socioeconomic status found the intervention equally effective in different socioeconomic groups. The intervention is effective in previous non-participants, who are frequently characterized by lower socioeconomic status or specific ethnic profiles.

Discussion

A number of results seem to be observed consistently between studies and across different countries and health systems. Both pre-screening reminders and GP endorsement led to higher participation rates (albeit modest increases) and were observed to do so in deprived and otherwise underserved populations.–,,,,, More personalized reminders for non-participants, whether by enhanced written materials or telephone contact (notably from primary care), were effective in increasing participation. These interventions too were successful in populations of low socioeconomic status.,,, Primary care endorsement and enhanced reminders for non-participants would incur almost no expense (other than the cost of screening larger numbers of people). In the UK, they might be expected to result in small, but arguably worthwhile, increases in participation. Larger increases might be expected in more deprived populations with lower current participation rates.

The choice of screening test itself is associated with participation. FIT is clearly more popular than other bowel screening modalities and was observed to increase participation by 15%–20%. HPV self-sampling raised participation rates, notably in previous non-participants, by around 10%. This is likely to be effective in socioeconomic or ethnic populations traditionally less easy to reach with cervical screening. Less consistent results were observed for different invitation strategies and home visits. Inclusion of questionnaires for research along with the invitations seemed to have a negative effect.

It is accepted that interventions to promote cancer screening should be non-coercive and should respect the principle of informed choice. However, it is also the case that there is a strong socioeconomic gradient in participation in screening, with lower participation being associated with lower socioeconomic status, and there is evidence that non-participants often report not having read the information provided. The search for interventions to remedy this would, therefore, seem to be ethically justified.

The classification of studies by intervention was arbitrary. For example, most of the HPV self-sampling studies included in Table 7 as interventions varying the screening test could have been included in Table 4 as interventions targeting non-participants. Similarly, some of the latter could have been included as primary care endorsement studies. However, the results are generally clear. It is also worth noting that, in classifying the studies, a degree of oversimplification was inevitable, in that some multi-component interventions have been classified into one category or another. One example is the study by Bell et al., which is classified as primary care endorsement, but which also included multilingual approaches and offers of transport to screening centre.

The magnitude of effects varied considerably, even within intervention types. The effects tended to be larger in environments where participation rates were relatively low. For example, reminder studies showing particularly large effects on participation were that of Baker et al. in Chicago, where opportunistic rather than organized screening was taking place, and one in inner north-east London, where there are large deprived populations, high levels of ethnic diversity, and usually low screening participation rates., Similarly, in the primary care endorsement studies, greatest effects were seen in populations with previously low participation.,

In the studies identified, the patient navigation approach, whereby a ‘navigator’ guides the patient/invitee through the complexities of a screening, diagnostic, or therapeutic process, was largely absent. However, some of the telephone interventions involved detailed scripts and briefing of the staff, so that they were able to answer questions; indeed, one such study in the context of bowel cancer screening showed good results. The concept of patient navigation is already established in the USA and may well spread to Europe in the immediate future.

We did not sub-classify the studies by design or quality but have noted in the tables whether the studies were randomized trials or observational studies. Of the 71 intervention studies, 52 (73%) were randomized, either by individual or cluster. The majority of positive results were seen in randomized studies.

As noted in the Methods section, due to time and resource considerations, we restricted our search to peer-reviewed publications listed in PubMed and adopted an unconventional expanding search strategy rather than a comprehensive search followed by successive narrowing by abstract and paper review. Although we only ceased the search expansion when it yielded relatively small numbers of potentially eligible publications and built in a safeguard by specifying that the search had to include a number of key publications, it is possible that some eligible material has been missed. Watt et al. advocate not a standard methodology for rapid review, but clear reporting and transparency with respect to the methods used. We have tried to adhere to this in terms of the description in the Methods section and the information in Table 1. It would be interesting if another group with the time and resources carried out a traditional systematic review, to see what, if anything, we have missed.

Conclusion

Interventions which were found most consistently to improve participation in cancer screening, including in underserved populations, were pre-screening reminders, general practice endorsement, more personalized reminders for non-participants, and offering a more acceptable screening test in cervical and bowel screening, both of which may suffer from social and cultural taboos.

References 84

  1. 1.

    NHS Cancer Screening Programmes. Consent to cancer screening 2009, https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/436770/cs4.pdf (accessed 15 January 2016).

    Not in our library

  2. 2.

    Marmot MG Altman DG Cameron DA et al. The independent UK panel on breast cancer screening: the benefits and harms of breast cancer screening: an independent review. Br J Cancer 2013; 11: 2205–2240.

    Not in our library10.1038/bjc.2013.177

  3. 3.

    Von Wagner C Baio G Raine R et al. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol 2011; 40: 712–718.

    Not in our library10.1093/ije/dyr008

  4. 4.

    Whynes DK Frew EJ Manghan CM et al. Colorectal cancer, screening and survival: the influence of socio-economic deprivation. BMC Public Health 2003; 117: 389–395.

    Not in our library10.1016/s0033-3506(03)00146-x

  5. 5.

    Szczepura A Price C Gumber A Breast and bowel cancer screening uptake patterns over 15 years for UK south Asian ethnic minority populations, corrected for differences in socio-demographic characteristics. BMC Public Health 2008; 8: 346.

    Not in our library10.1186/1471-2458-8-346

  6. 6.

    Department of Health. Equality objectives action plan 2012, https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/216801/DH-Equality-Objectives-Action-Plan.pdf (accessed 15 January 2016).

    Not in our library

  7. 7.

    Kerrison RS Shukla H Cunningham D et al. Text-message reminders increase uptake of routine breast screening appointments: a randomised controlled trial in a hard-to-reach population. Br J Cancer 2015; 112: 1005–1010.

    Not in our library10.1038/bjc.2015.36

  8. 8.

    Offman J Myles J Ariyanayagam S et al. A telephone reminder intervention to improve breast screening information and access. BMC Public Health 2014; 128: 1017–1022.

    Not in our library10.1016/j.puhe.2014.09.007

  9. 9.
  10. 10.

    Offman J Wilson M Lamont M et al. A randomised trial of weekend and evening breast screening appointments. Br J Cancer 2013; 109: 597–602.

    Not in our library10.1038/bjc.2013.377

  11. 11.
  12. 12.

    Ferroni E Camilloni L Jimenez B et al. Methods to increase participation Working Group. How to increase uptake in oncologic screening: a systematic review of studies comparing population-based screening programs and spontaneous access. Prev Med 2012; 55: 587–596.

    Not in our library10.1016/j.ypmed.2012.10.007

  13. 13.

    Spadea T Bellini S Kunst A et al. The impact of interventions to improve attendance in female cancer screening among lower socioeconomic groups: a review. Prev Med 2010; 50: 159–164.

    Not in our library10.1016/j.ypmed.2010.01.007

  14. 14.

    Black ME Yamada J Mann V A systematic literature review of the effectiveness of community-based strategies to increase cervical cancer screening. Can J Public Health 2002; 93: 386–393.

    Not in our library10.1007/bf03404575

  15. 15.

    Bonfill X Marzo M Pladevall M et al. Strategies for increasing women participation in community breast cancer screening. Cochrane Database Syst Rev 2001; 1: CD002943.

    Not in our library10.1002/14651858.cd002943

  16. 16.
  17. 17.

    White B Power E Ciurej M et al. Piloting the impact of three interventions on guaiac faecal occult blood test uptake within the NHS Bowel Cancer Screening Programme. Biomed Res Int 2015; 2015: 928251.

    Not in our library10.1155/2015/928251

  18. 18.

    Allgood PC Maxwell AJ Hudson S et al. A randomised trial of the effect of postal reminders on attendance for breast screening. Br J Cancer 2016; 114: 171–176.

    Not in our library10.1038/bjc.2015.451

  19. 19.

    Acera A Manresa JM Rodriguez D et al. Analysis of three strategies to increase screening coverage for cervical cancer in the general population of women aged 60 to 70 years: the CRICERVA study. BMC Womens Health 2014; 14: 86.

    Not in our library10.1186/1472-6874-14-86

  20. 20.

    Eaker S Adami HO Granath F et al. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 346–354.

    Not in our library

  21. 21.

    Baker DW Brown T Buchanan DR et al. Comparative effectiveness of a multifaceted intervention to improve adherence to annual colorectal cancer screening in community health centers: a randomized clinical trial. JAMA Intern Med 2012; 174: 1235–1241.

    Not in our library10.1001/jamainternmed.2014.2352

  22. 22.

    Shankleman J Massat NJ Khagram L et al. Evaluation of a service intervention to improve awareness and uptake of bowel cancer screening in ethnically-diverse areas. Br J Cancer 2014; 111: 1440–1447.

    Not in our library10.1038/bjc.2014.363

  23. 23.

    Arcas MM Buron A Ramis O et al. Can a mobile phone short message increase participation in breast cancer screening programmes? Rev Calid Asist 2014; 29: 188–196.

    Not in our library10.1016/j.cali.2014.02.003

  24. 24.

    Taplin SH Barlow WE Ludman E et al. Testing reminder and motivational telephone calls to increase screening mammography: a randomized study. J Natl Cancer Inst 2000; 92: 233–242.

    Not in our library10.1093/jnci/92.3.233

  25. 25.

    Vidal C Garcia M Benito L et al. Use of text-message reminders to improve participation in a population-based breast cancer screening program. J Med Syst 2014; 38: 118.

    Not in our library10.1007/s10916-014-0118-x

  26. 26.

    Lee MH Lee YY Jung da W et al. Effectiveness of interventions to increase the participation rate of gastric cancer screening in the Republic of Korea: a pilot study. Asian Pac J Cancer Prev 2012; 13: 861–866.

    Not in our library10.7314/apjcp.2012.13.3.861

  27. 27.

    Goelen G De Clercq G Hanssens S A community peer-volunteer telephone reminder call to increase breast cancer-screening attendance. Oncol Nurs Forum 2010; 37: E312–E317.

    Not in our library10.1188/10.onf.e312-e317

  28. 28.

    Atri J Falshaw M Gregg R et al. Improving uptake of breast screening in multiethnic populations: a randomised controlled trial using practice reception staff to contact non-attenders. BMJ 1997; 315: 1356–1359.

    Not in our library10.1136/bmj.315.7119.1356

  29. 29.

    Kearins O Walton J O'Sullivan E et al. Invitation management initiative to improve uptake of breast cancer screening in an urban UK Primary Care Trust. J Med Screen 2009; 16: 81–84.

    Not in our library10.1258/jms.2009.009006

  30. 30.

    Stead MJ Wallis MG Wheaton ME Improving uptake in non-attenders of breast screening: selective use of second appointment. J Med Screen 1998; 5: 69–72.

    Not in our library10.1136/jms.5.2.69

  31. 31.

    Turner KM Wilson BJ Gilbert FJ Improving breast screening uptake: persuading initial non-attenders to attend. J Med Screen 1994; 1: 199–202.

    Not in our library10.1177/096914139400100313

  32. 32.

    Fleming P Mooney T Fitzpatrick P Impact of second reminder invitation on uptake of screening and cancer detection in BreastCheck. Ir Med J 2012; 105: 7–9.

    Not in our library

  33. 33.

    Hayes C O'Herlihy B Hynes M et al. The impact of reminder letters on attendance for breast cancer screening. Ir J Med Sci 1999; 168: 29–32.

    Not in our library10.1007/bf02939577

  34. 34.

    Hegenscheid K Hoffmann W Fochler S et al. Telephone counseling and attendance in a national mammography-screening program a randomized controlled trial. Am J Prev Med 2011; 41: 421–427.

    Not in our library10.1016/j.amepre.2011.06.040

  35. 35.

    Jensen H Svanholm H Støvring H et al. A primary healthcare-based intervention to improve a Danish cervical cancer screening programme: a cluster randomised controlled trial. J Epidemiol Community Health 2009; 63: 510–515.

    Not in our library10.1136/jech.2008.077636

  36. 36.

    Oscarsson MG Benzein EG Wijma BE et al. Promotion of cervical screening among nonattendees: a partial cost-effectiveness analysis. Eur J Cancer Prev 2007; 16: 559–563.

    Not in our library10.1097/cej.0b013e3280145e60

  37. 37.

    Stein K Lewendon G Jenkins R et al. Improving uptake of cervical cancer screening in women with prolonged history of non-attendance for screening: a randomized trial of enhanced invitation methods. J Med Screen 2005; 12: 185–189.

    Not in our library10.1258/096914105775220741

  38. 38.

    Heranney D Fender M Velten M et al. A prospective randomized study of two reminding strategies: telephone versus mail in the screening of cervical cancer in women who did not initially respond. Acta Cytol 2011; 55: 334–340.

    Not in our library10.1159/000327527

  39. 39.

    Tinmouth J Patel J Austin PC et al. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders. Int J Cancer 2015; 136: E697–E703.

    Not in our library10.1002/ijc.29191

  40. 40.

    Steele RJ Kostourou I McClements P et al. Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: analysis of prevalence and incidence screening. BMJ 2010; 341: c5531.

    Not in our library10.1136/bmj.c5531

  41. 41.

    Senore C Ederle A DePretis G et al. Invitation strategies for colorectal cancer screening programmes: the impact of an advance notification letter. Prev Med 2015; 73: 106–111.

    Not in our library10.1016/j.ypmed.2015.01.005

  42. 42.

    Helander S Hakama M Malila N Effect of a pre-screening survey on attendance in colorectal cancer screening: a double-randomized study in Finland. J Med Screen 2014; 21: 82–88.

    Not in our library10.1177/0969141314534229

  43. 43.

    Cole SR Smith A Wilson C et al. An advance notification letter increases participation in colorectal cancer screening. J Med Screen 2007; 14: 73–75.

    Not in our library10.1258/096914107781261927

  44. 44.

    Page A Morrell S Tewson R et al. Mammography screening participation: effects of a media campaign targeting Italian-speaking women. Aust N Z J Public Health 2005; 29: 365–371.

    Not in our library10.1111/j.1467-842x.2005.tb00208.x

  45. 45.

    Nguyen TT McPhee SJ Bui-Tong N et al. Community-based participatory research increases cervical cancer screening among Vietnamese-Americans. J Health Care Poor Underserved 2006; 17(2 Suppl): 31–54.

    Not in our library10.1353/hpu.2006.0091

  46. 46.

    Taylor V Thompson B Lessler D et al. A clinic-based mammography intervention targeting inner-city women. J Gen Intern Med 1999; 14: 104–111.

    Not in our library10.1046/j.1525-1497.1999.00295.x

  47. 47.

    Wardle J Williamson S McCaffery K et al. Increasing attendance at colorectal cancer screening: testing the efficacy of a mailed, psychoeducational intervention in a community sample of older adults. Health Psychol 2003; 22: 99–105.

    Not in our library10.1037//0278-6133.22.1.99

  48. 48.

    Mant D Fuller A Northover J et al. Patient compliance with colorectal cancer screening in general practice. Br J Gen Pract 1992; 42: 18–20.

    Not in our library

  49. 49.

    Banks E Richardson A Beral V et al. Effect on attendance at breast cancer screening of adding a self-administered questionnaire to the usual invitation to breast screening in southern England. J Epidemiol Community Health 1998; 52: 116–119.

    Not in our library10.1136/jech.52.2.116

  50. 50.

    Giordano L Stefanini V Senore C et al. The impact of different communication and organizational strategies on mammography screening uptake in women aged 40-45 years. Eur J Public Health 2012; 22: 413–418.

    Not in our library10.1093/eurpub/ckr090

  51. 51.

    Segnan N Senore C Giordano L et al. Promoting participation in a population screening program for breast and cervical cancer: a randomized trial of different invitation strategies. Tumori 1998; 84: 348–853.

    Not in our library10.1177/030089169808400307

  52. 52.

    Youl PH Janda M Lowe JB et al. Does the type of promotional material influence men's attendance at skin screening clinics? Health Promot J Aust 2005; 16: 229–232.

    Not in our library10.1071/he05229

  53. 53.

    Hoare T Thomas C Biggs A et al. Can the uptake of breast screening by Asian women be increased? A randomized controlled trial of a linkworker intervention. J Public Health Med 1994; 16: 179–185.

    Not in our library10.1093/oxfordjournals.pubmed.a042954

  54. 54.

    Segura JM Castells X Casamitjana M et al. A randomized controlled trial comparing three invitation strategies in a breast cancer screening program. Prev Med 2001; 33: 325–332.

    Not in our library10.1006/pmed.2001.0891

  55. 55.

    Chalapati W Chumworathayi B Can a home-visit invitation increase Pap smear screening in Samliem, Khon Kaen, Thailand? Asian Pac J Cancer Prev 2007; 8: 119–123.

    Not in our library

  56. 56.

    Watson J Shaw K Macgregor M et al. Bowel screening follow-up study investigators and collaborators. Use of research questionnaires in the NHS Bowel Cancer Screening Programme in England: impact on screening uptake. J Med Screen 2013; 20: 192–197.

    Not in our library10.1177/0969141313511447

  57. 57.

    Giorgi Rossi P Grazzini G Anti M et al. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy. J Med Screen 2011; 18: 121–127.

    Not in our library10.1258/jms.2011.011009

  58. 58.

    Van Roosbroeck S Hoeck S Van Hal G Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies. Cancer Epidemiol 2012; 36: e317–e324.

    Not in our library10.1016/j.canep.2012.04.003

  59. 59.

    Courtier R Casamitjana M Macià F et al. Participation in a colorectal cancer screening programme: influence of the method of contacting the target population. Eur J Cancer Prev 2002; 11: 209–213.

    Not in our library10.1097/00008469-200206000-00003

  60. 60.

    Groth S Krause H Behrendt R et al. Capsule colonoscopy increases uptake of colorectal cancer screening. BMC Gastroenterol 2012; 12: 80.

    Not in our library10.1186/1471-230x-12-80

  61. 61.

    Gupta S Halm EA Rockey DC et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med 2013; 173: 1725–1732.

    Not in our library10.1001/jamainternmed.2013.9294

  62. 62.

    Santare D Kojalo I Huttunen T et al. Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use. Eur J Gastroenterol Hepatol 2015; 27: 536–543.

    Not in our library10.1097/meg.0000000000000314

  63. 63.

    Haguenoer K Sengchanh S Gaudy-Graffin C et al. Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial. Br J Cancer 2014; 111: 2187–2196.

    Not in our library10.1038/bjc.2014.510

  64. 64.

    Broberg G Gyrd-Hansen D Miao Jonasson J et al. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer 2014; 134: 2223–2230.

    Not in our library10.1002/ijc.28545

  65. 65.

    Giorgi Rossi P Fortunato C Barbarino P et al. HPV Self-sampling Italian Working Group. Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies, and recall letter. Br J Cancer 2015; 112: 667–675.

    Not in our library10.1038/bjc.2015.11

  66. 66.
  67. 67.

    Darlin L Borgfeldt C Forslund O et al. Comparison of use of vaginal HPV self-sampling and offering flexible appointments as strategies to reach long-term non-attending women in organized cervical screening. J Clin Virol 2013; 58: 155–160.

    Not in our library10.1016/j.jcv.2013.06.029

  68. 68.

    Virtanen A Nieminen P Luostarinen T et al. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol Biomarkers Prev 2011; 20: 1960–1969.

    Not in our library10.1158/1055-9965.epi-11-0307

  69. 69.

    Gök M Heideman DA van Kemenade FJ et al. HPV testing on self-collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 2010; 340: c1040.

    Not in our library10.1136/bmj.c1040

  70. 70.

    Gray M Pennington CR Screening sigmoidoscopy: a randomised trial of invitation style. Health Bull (Edinb) 2000; 58: 137–140.

    Not in our library

  71. 71.

    Barthe J Perrodeau E Gilberg S et al. Impact of a doctor's invitation on participation in colorectal cancer screening: a cluster randomized trial. Am J Med 2015; 128: 1024.

    Not in our library10.1016/j.amjmed.2015.03.026

  72. 72.

    Bell TS Branston LK Newcombe RG et al. Interventions to improve uptake of breast screening in inner city Cardiff general practices with ethnic minority lists. Ethn Health 1999; 4: 277–284.

    Not in our library10.1080/13557859998056

  73. 73.

    Giorgi D Giordano L Senore C et al. General practitioners and mammographic screening uptake: influence of different modalities of general practitioner participation. Working Group. Tumori 2000; 86: 124–129.

    Not in our library10.1177/030089160008600203

  74. 74.

    Dorsch MM Cheok F Ingham HM The effectiveness of invitations from general practitioners in recruiting women to mammographic screening. Med J Aust 1991; 155: 623–625.

    Not in our library10.5694/j.1326-5377.1991.tb93932.x

  75. 75.

    Eilbert KW Carroll K Peach J et al. Approaches to improving breast screening uptake: evidence and experience from Tower Hamlets. Br J Cancer 2009; 101(Suppl. 2): S64–S67.

    Not in our library10.1038/sj.bjc.6605393

  76. 76.

    De Nooijer DP De Waart FG Van Leeuwen AW et al. Participation in the Dutch national screening programme for uterine cervic cancer higher after invitation by a general practitioner, especially in groups with a traditional low level of attendance. Ned Tijdschr Geneeskd 2005; 149: 2339–2343.

    Not in our library

  77. 77.

    Hermens RP Tacken MA Hulscher ME et al. Attendance to cervical cancer screening in family practices in The Netherlands. Prev Med 2000; 30: 35–42.

    Not in our library10.1006/pmed.1999.0603

  78. 78.

    Zajac IT Whibley AH Cole SR et al. Endorsement by the primary care practitioner consistently improves participation in screening for colorectal cancer: a longitudinal analysis. J Med Screen 2010; 17: 19–24.

    Not in our library10.1258/jms.2010.009101

  79. 79.

    Cole SR Young GP Byrne D et al. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. J Med Screen 2002; 9: 147–152.

    Not in our library10.1136/jms.9.4.147

  80. 80.

    Wardle J Robb K Vernon S et al. Screening for prevention and early diagnosis of cancer. Am Psychol 2015; 70: 119–133.

    Not in our library10.1037/a0037357

  81. 81.

    Kobayashi LC Waller J von Wagner C et al. Differences in information engagement between accepters and decliners of cancer screening in England: implications for communication and informed choice. Cancer Research UK, London: University College London, 2015.

    Not in our library

  82. 82.

    Freeman HP Patient navigation as a targeted intervention: for patients at high risk for delays in cancer care. Cancer 2015; 121: 4025–4034.

    Not in our library10.1002/cncr.29610

  83. 83.
  84. 84.

    Watt A Cameron A Sturm L et al. Rapid reviews versus full systematic reviews: an inventory of current methods and practice in health technology assessment. Int J Technol Assess Health Care 2008; 24: 133–139.

    Not in our library10.1017/s0266462308080185

Cited by papers we hold 2

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.